A multiplex assay to assess activated p300/CBP in circulating prostate tumour cells - ecancer
ecancer,
A new research paper was published inOncotarget'sVolume 14on July 20, 2023, entitled, Development of a multiplex assay to…
A new research paper was published inOncotarget'sVolume 14on July 20, 2023, entitled, Development of a multiplex assay to…
Eine neue Forschungsarbeit wurde veröffentlicht in mit dem Titel „Entwicklung eines Multiplex-Assays zur Beurteilung von…
A new research paper was published in Oncotarget's Volume 14 on July 20, 2023, entitled, "Development of a multiplex assay to…
A new research paper was published in Oncotarget, titled, "Development of a multiplex assay to assess activated p300/CBP in…
“The results from this initial cohort support the integration of these biomarkers into prospective clinical trials.” Credit…
“The results from this initial cohort support the integration of these biomarkers into prospective clinical trials.” Credit…
image: Figure 1: Optimization of circulating tumor cells (CTC) staining and validation of p300 activity.
"The results from this initial cohort support the integration of these biomarkers into prospective clinical trials." BUFFALO, NY…
The results from this initial cohort support the integration of these biomarkers into prospective clinical trials.